Outcome measures
anxiety, Functional disability, insomnia, Insomnia, depressive symptoms, Depression
SHEEHAN, SECONDARY
Self-report outcome measures were collected at baseline (Week 0), immediate post-intervention (Week 9), and 1-month post-intervention (LH only; Week 13). The primary outcome was overall mental health conditions as assessed by the Chinese version of Depression Anxiety Stress Scales-21 (DASS-21) (The secondary outcomes included depressive symptoms, anxiety symptoms, stress levels, insomnia severity, functional disability, HRQOL, HPBs, and intervention acceptability. The Chinese version of the Insomnia Severity Index (ISI) (Functional disability was measured by the Chinese version of the Sheehan Disability Scale (SDS) on an 11-point Likert scale (HRQOL was measured by the Hong Kong version of the Short Form (Six-Dimension) Health Survey (SF-6D) (HPBs were assessed using the Chinese version of the Health-Promoting Lifestyle Profile (HPLP-II) (The Chinese version of the Credibility-Expectancy Questionnaire (CEQ) was adopted to evaluate intervention acceptability (